Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

Question 2

How does pembrolizumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma clinical trial (NCT07007273). Contact the study team or your healthcare provider for specific answers.

What this study is about